Site Finder

Top 40 Global FIH Phase I Trial Sites ranked by SRS Score — trial volume, institutional capability, startup speed, PI quality, and geographic diversity.

1

Sarah Cannon Research Institute

Private Phase I

Nashville, United States

112Trials122Pubs
62.0
SRS
2

MD Anderson Cancer Center

Academic NCI

Houston, United States

174Trials177Pubs
59.0
SRS
3

Dana-Farber Cancer Institute

Academic NCI

Boston, United States

89Trials83Pubs
59.0
SRS
4

Memorial Sloan Kettering Cancer Center

Academic NCI

New York, United States

81Trials107Pubs
59.0
SRS
5

City of Hope

Academic NCI

Duarte, United States

67Trials59Pubs
56.1
SRS
6

Vall d'Hebron (VHIO)

Academic

Barcelona, Spain

70Trials66Pubs
55.8
SRS
7

Massachusetts General Hospital

Academic

Boston, United States

46Trials65Pubs
55.4
SRS
8

NCC Hospital Tokyo

Academic

Kashiwa-shi, Japan

59Trials60Pubs
53.5
SRS
9

Institut Gustave Roussy

Academic

Villejuif, France

42Trials57Pubs
52.4
SRS
10

Fred Hutchinson Cancer Center

Academic NCI

Seattle, United States

34Trials37Pubs
47.9
SRS
11

Florida Cancer Specialists

Private Phase I

Sarasota, United States

43Trials26Pubs
46.8
SRS
12

Royal Marsden Hospital

Academic

London, United Kingdom

36Trials38Pubs
45.2
SRS
13

NEXT Oncology

Private Phase I

Dallas, United States

86Trials21Pubs
44.9
SRS
14

START Midwest

Private Phase I

Grand Rapids, United States

43Trials17Pubs
43.4
SRS
15

Moffitt Cancer Center

Academic NCI

Tampa, United States

34Trials25Pubs
43.4
SRS
16

Asan Medical Center

Academic

Seoul, South Korea

52Trials31Pubs
42.6
SRS
17

Seoul National University Hospital

Academic

Seoul, South Korea

46Trials31Pubs
42.6
SRS
18

Samsung Medical Center

Academic

Seoul, South Korea

51Trials20Pubs
38.5
SRS
19

NEXT Virginia

Private Phase I

Fairfax, United States

31Trials0Pubs
34.9
SRS
20

NTUH

Academic

Taipei, Taiwan

29Trials18Pubs
33.8
SRS
21

Beijing Cancer Hospital

Academic

Beijing, China

31Trials4Pubs
30.4
SRS
22

Virginia Cancer Specialists

Academic

Fairfax, United States

26Trials10Pubs
28.1
SRS
23

SCRI Oncology Partners

Academic

Nashville, United States

29Trials0Pubs
27.1
SRS
24

Hospital Universitario 12 de Octubre

Academic

Madrid, Spain

26Trials7Pubs
27.0
SRS
25

Seoul National University Bundang Hospital

Academic

Seongnam-si, South Korea

25Trials8Pubs
26.5
SRS
26

Karmanos Cancer Institute

Academic

Detroit, United States

23Trials0Pubs
21.7
SRS
27

Roswell Park Cancer Center

Academic NCI

Buffalo, United States

19Trials0Pubs
21.1
SRS
28

Princess Margaret Cancer Centre

Academic

Toronto, Canada

22Trials0Pubs
20.8
SRS
29

Peter MacCallum Cancer Centre

Academic

Melbourne, Australia

22Trials0Pubs
20.8
SRS
30

Fudan Shanghai Cancer Center

Academic

Shanghai, China

22Trials0Pubs
20.8
SRS
31

Research Site

Academic

La Jolla, United States

21Trials0Pubs
19.9
SRS
32

Zhejiang Cancer Hospital

Academic

Hangzhou, China

19Trials0Pubs
18.1
SRS
33

Johns Hopkins

Academic

Washington D.C., United States

18Trials0Pubs
17.2
SRS
34

Hunan Cancer Hospital

Academic

Changsha, China

18Trials0Pubs
17.2
SRS
35

Yale Cancer Center

Academic

New Haven, United States

18Trials0Pubs
17.2
SRS
36

Washington University School of Medicine

Academic

St Louis, United States

18Trials0Pubs
17.2
SRS
37

Cleveland Clinic

Academic

Cleveland, United States

18Trials0Pubs
17.2
SRS
38

Henan Cancer Hospital

Academic

Zhengzhou, China

18Trials0Pubs
17.2
SRS
39

Shanghai East Hospital

Academic

Shanghai, China

17Trials0Pubs
16.3
SRS
40

Severance Hospital, Yonsei University Health System

Academic

Seoul, South Korea

16Trials0Pubs
15.4
SRS

40 sites scored by SRS. Data: ClinicalTrials.gov + PubMed (2020-2026).